iSpecimen Inc.
ISPC- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001558569
No open-market purchases or sales by iSpecimen Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $152.0K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding iSpecimen Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 13 | 14 | +1 |
| Shares | 475.6K | 496.3K | +20.7K (+4.4%) |
| Value | $653.0K | $665.4K | +$12.4K (+1.9%) |
New holders (2)
Institutions that held iSpecimen Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 13,805 | $18.5K | 0.00% |
| Susquehanna International Group, LLP | 12,851 | $17.3K | 0.00% |
Sold out (1)
Institutions that held iSpecimen Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Bank of America Corp | 12 | $16 |